Melanotan II (MT2) 10mg
€ 54,00
Melanotan II also known as MT2 10 mg – Grail Formula Quality. Researched and verified with Liquilabs s.r.o. Czechia. Analytical validation confirms purity 99.8%, assay content 11.22 mg, RT identification 0.998 and spectrum 996. Endotoxin below 0.001 EU per mg, with no detectable heavy metals or microbial contamination. Supplied as a 10 mg lyophilized peptide with full COA traceability. Within Europe this product is supplied including bacteriostatic water; outside the EU only the peptide vial is provided. For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.
For research use only – not for human or veterinary use.
Product Overview
Melanotan II also known as MT2 is a research peptide studied for its relevance to melanocortin-pathway modelling receptor-binding behaviour and controlled biochemical signalling evaluation. This lyophilized 10 mg preparation supports laboratory analysis of purity identity and mechanistic activity.
Peptide Overview
Between 2009 and 2025 Melanotan II gained extensive research attention due to its well-characterised interaction with melanocortin receptors and its reproducible analytical behaviour in in-vitro systems. Its stable structure supports controlled pathway-modelling and receptor-mechanism studies.
Historical Background and Scientific Context
Scientific interest in MT2 expanded significantly as research groups explored melanocortin signalling patterns and peptide–receptor integration models. Melanotan II became a reference compound for comparative ligand-binding and pathway-regulation analysis in controlled settings.
Mechanistic Focus in Research
- Melanocortin-pathway signalling modelling
- Receptor-binding and biochemical interaction studies
- Comparative peptide-mechanism profiling
- Controlled in-vitro signalling experiments
- Structure–function pathway evaluation
Analytical Verification (COA)
Independent Liquilabs analysis confirms validation for Batch GF112025065. Key results include:
- Assay Content: 11.22 mg
- Identification – Retention Time: 0.998
- Identification – Spectrum: 996
- Purity: 99.8%
- Endotoxins: below 0.001 EU per mg
- Microbial Growth: not detected for aerobic count yeast or mold
- Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury and vanadium
All analytical values were obtained using validated chromatographic spectroscopic and microbiological procedures ensuring full traceability and transparent documentation.
Research Applications
- Receptor-binding and melanocortin-pathway modelling
- Biochemical signalling evaluation
- Comparative ligand-binding analysis
- Controlled pathway-modelling experiments
- Structure–function biochemical studies
Grail Formula Quality
Every Grail Formula research peptide undergoes independent laboratory verification for purity identity structural integrity and microbial safety. All batches are validated for stability and reproducibility ensuring consistent scientific outcomes.
When You Choose Grail Formula…
Researchers receive fully documented peptides with batch-number traceability sealed-vial integrity and transparent laboratory validation. EU shipments include sterile bacteriostatic water; outside Europe only the peptide vial is supplied.
For research use only – not for human or veterinary use.
- Verified and analysed with Liquilabs s.r.o. Czechia
- Purity 99.8% with validated assay content
- No detectable heavy metals or microbial contamination
- Endotoxin level below 0.001 EU per mg
- Batch GF112025065 – Published November 2025
- EU shipments include bacteriostatic water
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
